SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 425 - Prospectuses and communications, business combinations:
SEC Accession No. 0001485003-23-000012
Filing Date
2023-01-30
Accepted
2023-01-30 08:12:46
Documents
7

Document Format Files

Seq Description Document Type Size
1 425 sesnformnasdaqdelistingnot.htm 425 31603
2 EX-99.1 ex991nasdaqdelistingnoti.htm EX-99.1 17970
3 ex991nasdaqdelistingnoti001.jpg GRAPHIC 235087
4 ex991nasdaqdelistingnoti002.jpg GRAPHIC 261549
5 ex991nasdaqdelistingnoti003.jpg GRAPHIC 336571
6 ex991nasdaqdelistingnoti004.jpg GRAPHIC 274701
7 ex991nasdaqdelistingnoti005.jpg GRAPHIC 29540
  Complete submission text file 0001485003-23-000012.txt   1618406
Mailing Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142
Business Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142 617-444-8550
Sesen Bio, Inc. (Filed by) CIK: 0001485003 (see all company filings)

IRS No.: 262025616 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 425
SIC: 2834 Pharmaceutical Preparations

Mailing Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142
Business Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142 617-444-8550
Sesen Bio, Inc. (Subject) CIK: 0001485003 (see all company filings)

IRS No.: 262025616 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 425 | Act: 34 | File No.: 001-36296 | Film No.: 23565313
SIC: 2834 Pharmaceutical Preparations